Atlas Trials

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Clinical trial NCT01262391 · COMPLETED

Trial details

NCT number
NCT01262391
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Urinary Bladder, Overactive
Start date
2010-10-20
Primary completion
2011-08-14
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.